Advanced Practice Midwife in Lakeland, FL Accepting Medicare

7 Advanced Practice Midwife nurses found. Showing 1 - 7

Carolyn M Reneau, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1729 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-940-2908    Fax: 863-940-4722

Natalie Anne Wipert, APRN Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1129 N Missouri Ave, Lakeland, FL 33805 Phone: 866-234-8534

Ms. Kimona Baker, ARNP;CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1729 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-940-2908    Fax: 813-938-6485

Mrs. Mickelyn Graves Houghton, APRN-CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1129 N Missouri Ave, Lakeland, FL 33805 Phone: 866-234-8534

Jill Allison Young, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1525 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-284-6860    Fax: 863-688-7959

Tammy Hatcher, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1729 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-940-2908    Fax: 813-938-6425

Triana Monez Boggs, APRN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1923 S Florida Ave, Lakeland, FL 33803 Phone: 863-683-4663

News Archive

Democrats link GOP challengers to Trump's COVID record, efforts to undo Obamacare

In a tweet to his 78,000 followers Sunday, U.S. Rep. Harley Rouda, a Democrat from Orange County, California, described his Republican opponent Michelle Steel's attendance at an indoor fundraiser without a mask as "sickening."

FDA to take enforcement action regarding Genzyme's Allston plant

Genzyme Corporation announced today that the FDA notified the company yesterday afternoon that, while the agency recognizes Genzyme's efforts, it intends to take enforcement action to ensure that products manufactured at the plant are made in compliance with good manufacturing practice regulations. The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant's operation for an extended period and certify compliance with FDA regulations.

Alnylam commences ALN-PCS Phase I trial in severe hypercholesterolemia

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.

FDA approves Rituxan-corticosteroid combination for Wegener's Granulomatosis and Microscopic Polyangiitis

Genentech, a member of the Roche Group and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab), in combination with corticosteroids, as a new medicine for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).

Read more Medical News

› Verified 6 days ago